ICD Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Seung-Ho Lee

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	17.2%
Management average tenure	no data
Board average tenure	no data

Recent management updates

Recent updates

ICD Co., Ltd.'s (KOSDAQ:040910) 47% Price Boost Is Out Of Tune With Revenues

Apr 08

The Attractive Combination That Could Earn ICD Co., Ltd. (KOSDAQ:040910) A Place In Your Dividend Portfolio

Apr 08

Are Robust Financials Driving The Recent Rally In ICD Co., Ltd.'s (KOSDAQ:040910) Stock?

Feb 01

Under The Bonnet, ICD's (KOSDAQ:040910) Returns Look Impressive

Jan 19

Is ICD Co., Ltd. (KOSDAQ:040910) An Attractive Dividend Stock?

Jan 06

Be Sure To Check Out ICD Co., Ltd. (KOSDAQ:040910) Before It Goes Ex-Dividend

Dec 24

Is ICD's (KOSDAQ:040910) Share Price Gain Of 142% Well Earned?

Dec 13

We Think ICD (KOSDAQ:040910) Can Manage Its Debt With Ease

Nov 30

CEO

Seung-Ho Lee (66 yo)

no data

Tenure

Mr. Seung Ho Lee serves as the Chief Executive Officer and Director of ICD Co., Ltd.

ICD Management

Management criteria checks 0/4

Key information

Recent management updates

No independent directors

No independent directors

ICD Co., Ltd., Annual General Meeting, Mar 26, 2021

Recent updates

ICD Co., Ltd. announced that it has received KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Kiwoomfni Co., Ltd., Shinhan Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd.

ICD Co., Ltd. announced that it expects to receive KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Kiwoomfni Co., Ltd., Shinhan Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd.

ICD Co., Ltd.'s (KOSDAQ:040910) 47% Price Boost Is Out Of Tune With Revenues

New minor risk - Share price stability

New minor risk - Market cap size

Upcoming dividend of ₩100.00 per share at 1.1% yield

New minor risk - Shareholder dilution

New major risk - Dividend sustainability

Investor sentiment improves as stock rises 20%

Investor sentiment improves as stock rises 18%

Upcoming dividend of ₩200 per share

No independent directors

ICD Co., Ltd. (KOSDAQ:A040910) announces an Equity Buyback for KRW 3,000 million worth of its shares.

No independent directors

Upcoming dividend of ₩350 per share

ICD Co., Ltd. announced that it has received KRW 18000 billion in funding from Eugene Investment & Securities Co.,Ltd.

First quarter 2021 earnings released: EPS ₩131 (vs ₩446 in 1Q 2020)

The Attractive Combination That Could Earn ICD Co., Ltd. (KOSDAQ:040910) A Place In Your Dividend Portfolio

ICD (KOSDAQ:040910) Could Easily Take On More Debt

New 90-day low: ₩15,750

When Should You Buy ICD Co., Ltd. (KOSDAQ:040910)?

Price target lowered to ₩22,500

ICD Co., Ltd., Annual General Meeting, Mar 26, 2021

If You Like EPS Growth Then Check Out ICD (KOSDAQ:040910) Before It's Too Late

Are Robust Financials Driving The Recent Rally In ICD Co., Ltd.'s (KOSDAQ:040910) Stock?

Under The Bonnet, ICD's (KOSDAQ:040910) Returns Look Impressive

Is ICD Co., Ltd. (KOSDAQ:040910) An Attractive Dividend Stock?

Be Sure To Check Out ICD Co., Ltd. (KOSDAQ:040910) Before It Goes Ex-Dividend

Upcoming Dividend of ₩150 Per Share

New 90-day high: ₩17,550

Is ICD's (KOSDAQ:040910) Share Price Gain Of 142% Well Earned?

We Think ICD (KOSDAQ:040910) Can Manage Its Debt With Ease

Third quarter 2020 earnings released: EPS ₩1,265

New 90-day low: ₩14,200

New 90-day high - ₩17,400

CEO

Tenure